[{"id":"44b09edb-cd29-47be-ab28-ad38f4d77ec1","acronym":"","url":"https://clinicaltrials.gov/study/NCT05367635","created_at":"2022-05-10T20:53:39.752Z","updated_at":"2024-07-02T16:35:31.999Z","phase":"Phase 1","brief_title":"A Study of SKB315 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT05367635","lead_sponsor":"Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.","biomarkers":" CLDN18","pipe":"","alterations":" ","tags":["CLDN18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SKB315"],"overall_status":"Recruiting","enrollment":" Enrollment 206","initiation":"Initiation: 03/16/2022","start_date":" 03/16/2022","primary_txt":" Primary completion: 05/31/2024","primary_completion_date":" 05/31/2024","study_txt":" Completion: 05/31/2024","study_completion_date":" 05/31/2024","last_update_posted":"2023-10-24"}]